Hepatitis C virus and other flaviviridae viruses enter cells via low density lipoprotein receptor.

Endocytosis of the Flaviviridae viruses, hepatitis C virus, GB virus C/hepatitis G virus, and bovine viral diarrheal virus (BVDV) was shown to be mediated by low density lipoprotein (LDL) receptors on cultured cells by several lines of evidence: by the demonstration that endocytosis of these virus correlated with LDL receptor activity, by complete inhibition of detectable endocytosis by anti-LDL receptor antibody, by inhibition with anti-apolipoprotein E and -apolipoprotein B antibodies, by chemical methods abrogating lipoprotein/LDL receptor interactions, and by inhibition with the endocytosis inhibitor phenylarsine oxide. Confirmatory evidence was provided by the lack of detectable LDL receptor on cells known to be resistant to BVDV infection. Endocytosis via the LDL receptor was shown to be mediated by complexing of the virus to very low density lipoprotein or LDL but not high density lipoprotein. Studies using LDL receptor-deficient cells or a cytolytic BVDV system indicated that the LDL receptor may be the main but not exclusive means of cell entry of these viruses. Studies on other types of viruses indicated that this mechanism may not be exclusive to Flaviviridae but may be used by viruses that associate with lipoprotein in the blood. These findings provide evidence that the family of LDL receptors may serve as viral receptors.

[1]  H. Okamoto,et al.  Association of circulating hepatitis G virus with lipoproteins for a lack of binding with antibodies. , 1996, Biochemical and biophysical research communications.

[2]  M. Ackermann,et al.  Porcine reproductive and respiratory syndrome virus enters cells through a low pH-dependent endocytic pathway. , 1996, Virus research.

[3]  E. Kuechler,et al.  Members of the low density lipoprotein receptor family mediate cell entry of a minor-group common cold virus. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[4]  S. Ranganathan,et al.  A rapid flow cytometric assay for low-density lipoprotein receptors in human peripheral blood mononuclear cells. , 1995, The Journal of laboratory and clinical medicine.

[5]  C. Dinarello,et al.  Biologic basis for interleukin-1 in disease. , 1996, Blood.

[6]  E. Rassart,et al.  The epitopes of apolipoprotein A-I define distinct structural domains including a mobile middle region. , 1991, The Journal of biological chemistry.

[7]  C C Howe,et al.  Human hepatocellular carcinoma cell lines secrete the major plasma proteins and hepatitis B surface antigen. , 1980, Science.

[8]  P. Chen,et al.  Human rheumatoid factor crossidiotypes. I. WA and BLA are heat-labile conformational antigens requiring both heavy and light chains , 1986, The Journal of experimental medicine.

[9]  S. Bombardieri,et al.  Cryoglobulinaemias: a multi-centre study of the early clinical and laboratory manifestations of primary and secondary disease. GISC. Italian Group for the Study of Cryoglobulinaemias. , 1995, QJM : monthly journal of the Association of Physicians.

[10]  H. Tilg,et al.  Induction of circulating IL-1 receptor antagonist by IFN treatment. , 1993, Journal of immunology.

[11]  R. Thomssen,et al.  Low density lipoprotein receptor as a candidate receptor for hepatitis C virus , 1999, Journal of medical virology.

[12]  Dina G. Fischer,et al.  An antiviral soluble form of the LDL receptor induced by interferon. , 1993, Science.

[13]  M. Yanagi,et al.  Contamination of commercially available fetal bovine sera with bovine viral diarrhea virus genomes: implications for the study of hepatitis C virus in cell cultures. , 1996, The Journal of infectious diseases.

[14]  R. Mahley,et al.  Inhibition of lipoprotein binding to cell surface receptors of fibroblasts following selective modification of arginyl residues in arginine-rich and B apoproteins. , 1977, The Journal of biological chemistry.

[15]  J. Kaptein,et al.  Flow cytometric evaluation of LDL receptors using DiI-LDL uptake and its application to B and T lymphocytic cell lines. , 1994, Journal of immunological methods.

[16]  T. Parker,et al.  Visualization of hepatitis C virions and putative defective interfering particles isolated from low‐density lipoproteins , 1996, Journal of viral hepatitis.

[17]  R. Donis,et al.  Isolation of a mutant MDBK cell line resistant to bovine viral diarrhea virus infection due to a block in viral entry. , 1995, Virology.

[18]  Y. Marcel,et al.  Use of bacterial expression cloning to localize the epitopes for a series of monoclonal antibodies against apolipoprotein B100. , 1990, The Journal of biological chemistry.

[19]  V. Agnello,et al.  A competitive reverse transcription-polymerase chain reaction assay for quantitation of GB virus C/hepatitis G virus RNA that circumvents heteroduplex artifact. , 1999, Journal of virological methods.

[20]  V. Agnello,et al.  Detection of widespread hepatocyte infection in chronic hepatitis C , 1998, Hepatology.

[21]  V. Bonagura,et al.  Human rheumatoid factor cross-idiotypes. IV. Studies on WA XId-positive IgM without rheumatoid factor activity provide evidence that the WA XId is not unique to rheumatoid factors and is distinct from the 17.109 and G6 XIds , 1993, The Journal of experimental medicine.

[22]  C. Packard,et al.  Receptor-mediated low density lipoprotein catabolism in man. , 1979, Journal of lipid research.

[23]  W. Stremmel,et al.  Establishment of persistent hepatitis C virus infection and replication in vitro. , 1997, The Journal of general virology.

[24]  E. J. Stott,et al.  Viral contamination of bovine foetal serum and cell cultures , 1977, Nature.

[25]  N. Cooper,et al.  Antibody-independent neutralization of vesicular stomatitis virus by human complement. II. Formation of VSV-lipoprotein complexes in human serum and complement-dependent viral lysis. , 1978, Journal of immunology.

[26]  H. Varmus,et al.  A receptor for subgroup A Rous sarcoma virus is related to the low density lipoprotein receptor , 1993, Cell.

[27]  V. Agnello,et al.  Localization of hepatitis C virus in cutaneous vasculitic lesions in patients with type II cryoglobulinemia. , 1997, Arthritis and rheumatism.

[28]  R. Mahley,et al.  The receptor-binding domain of human apolipoprotein E. Monoclonal antibody inhibition of binding. , 1983, The Journal of biological chemistry.

[29]  Carolyn A. Converse,et al.  Lipoprotein analysis : a practical approach , 1992 .

[30]  R. Chung,et al.  A role for hepatitis C virus infection in type II cryoglobulinemia. , 1992, The New England journal of medicine.

[31]  P. Tijssen,et al.  Identification of a new group of bovine viral diarrhea virus strains associated with severe outbreaks and high mortalities. , 1994, Virology.